DPHARMA | CCM DUOPHARMA BIOTECH BHD*

1.36 (2.26%)
Last updated: 17:00
Fundamental   5.4  
Technical   3.2  
Total Score   8.6  

 Insti+   Heikin Ashi+ 
DPHARMA | CCM DUOPHARMA BIOTECH BHD

iSaham Fundamental Trend - DPHARMA

FCON: 0.64 | Sharpe Ratio: 0.61 | LTS: 7.85



Financial Ratios - DPHARMA



EPS 7.81 sen
Trailing PE (Sector Median: 14.5) 17.5
PEG -5.89
Altman Z 1.3
Beaver -0.045
Current Ratio 1.62
Debt-Equity (DE) Ratio 0.76
FCF Yield -3.18 %
Dividend Per Share (DPS) 5.5 sen
Revenue QoQ 12.85 %
Revenue YoY 7.93 %
Profit QoQ 34.16 %
Profit YoY 17.73 %
NTA QoQ 1.35 %
Profit Margin (Sector Median: 5.4) 9.98 %
ROE 10.33 %
ROIC 8.3 %
Dividend Yield (DY) 4.04 %

Support & Resistance

ATR Trailing Stop: 1.34

Support
Last Price
Resistance
Price 1.31 1.33 1.34 1.35 1.36 1.36 1.36 1.38 1.39 1.4 1.41
Volume (M) 11.5 7.5 22.0 21.2 32.8 32.8 35.1 12.2 17.9 11.1

Gann Support (EP/CL): 1.33/1.27 | Resistance (TP): 1.39/1.45

*Highlighted column shows significant volume at the support or resistance area.


Technical Trend


Moving Average Trend
Volume Trend


Trading Signalsbeta - DPHARMA

Based on iSaham Screeners

Moving Average (Short Term) HOLD
Moving Average (Mid Term) SELL
Moving Average (Long Term) BUY
Ichimoku Kumo HOLD
Bollinger Band BUY (Oversold Cross)
RSI BUY
Stochastic BUY
Heikin-Ashi BUY
MACD SELL
Solid MA Trend -
SAT HOLD
Sector Trend (Long Term) SELL
Sector Trend (Short Term) SELL
Institutional Holdings BUY
Beat The Insti BUY
Magic Formula -
Better Than ASB -
52-Week High -
BTST -
T+ -
Candlestick -
Chart Pattern -

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

Fair Value

iSaham Fair Value: 0.67

Discounted Cash Flow (DCF)5.0% Growth 0.67
Discounted Cash Flow (DCF)-2.8% Growth 0.375
Relative Valuation 1.13
Graham Formula 0.715
Graham Number 1.25
Net Tangible Asset (NTA) 0.75


Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 98.11
Expected Revenue (M) 1024.13
Expected Growth (%) 13.0


Summary

Market Cap: 898 M.

Number of Shares: 661 M.

Float: 40.43%.

Stock highly correlated with

HLIND (77%)

BJTOTO (74%)

KIANJOO (69%)

YEELEE (67%)

CCM Duopharma Biotech Berhad, an investment holding company, is engaged in the manufacture, distribution, import, and export of pharmaceutical products and medicines in Malaysia. It offers various over the-counter products, including oral antibiotics, cough syrups, analgesic/anti-pyretics, anti-bacterial mouthwash, children's vitamins, haemodialysis solutions, dental cartridges, and eye drop preparations. The company exports its products to various countries, including Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore, and Hong Kong. Founded in 1979, the company is based in Klang, Malaysia. CCM Duopharma Biotech Berhad is a subsidiary of CCM Marketing Sdn. Bhd.

Code: 7148

Website: http://duopharmabiotech.com/

Related Links: Bursa | Analyst Report | Annual Report | Announcement

AGM Doorgift: Pharmacy Products + RM10 TnG (2019) | AGM Announcement

Top Shareholdings

Updated on 29-Mar-2019

Shareholder Value (M)
Permodalan Nasional Berhad 406.75
Employees Provident Fund Board 56.41
Amanah Saham Bumiputera 34.0
Billion Victory Sdn. Bhd. 23.23
Employees Provident Fund Board 13.92
Amanah Saham Malaysia 13.6
Public Islamic Treasures Growth Fund 9.49
Credit Suisse 8.24
CIMB Islamic Dali Equity Theme Fund 6.28
Tokio Marine Life Insurance Malaysia Bhd 6.09
Kumpulan Wang Persaraan (Diperbadankan) 5.87
Kumpulan Wang Persaraan (Diperbadankan) 4.74
Kaf Dana Adib 4.46
Manulife Investment Progress Fund 4.16
CIMB Islamic Small Cap Fund 4.15
Amanah Saham Malaysia 3 4.07
National Trust Fund 3.76
Affin Hwang Principled Growth Fund 3.35
Leong Chao Seong 3.3
CIMB-Principal Small Cap Fund 3.25
Amtotal Return 3.21
Kaf Tactical Fund 3.01
Ooi Keng Tan 2.88
CIMB Islamic Trustee Berhad - Kenanga Syariah Growth Fund 2.67
Gibraltar BSN Aggressive Fund 2.59
Wong Kin Wah 2.26